Evidence map›Paper›PMID 31409921›Full record

ArticleLeukemia2020

Prognostic factors for adult single cord blood transplantation among European and Japanese populations: the Eurocord/ALWP-EBMT and JSHCT/JDCHCT collaborative study.

Junya Kanda, Hiromi Hayashi, Annalisa Ruggeri, Fumihiko Kimura, Fernanda Volt, Satoshi Takahashi, Myriam Labopin, Shinichi Kako, Karina Tozatto-Maio, Shingo Yano and 18 more

Abstract read
PubMed Publisher
In one paragraph

Article in Leukemia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Junya KandaDepartment of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. jkanda16@kuhp.kyoto-u.ac.jp.ORCID http://orcid.org/0000-0002-6704-3633
Hiromi HayashiEurocord, Hospital Saint Louis, AP-HP, IUH University Paris VII, Paris, France.
Annalisa RuggeriEurocord, Hospital Saint Louis, AP-HP, IUH University Paris VII, Paris, France.
Fumihiko KimuraDivision of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
Fernanda VoltEurocord, Hospital Saint Louis, AP-HP, IUH University Paris VII, Paris, France.
Satoshi TakahashiDivision of Molecular Therapy, The Advanced Clinical Research Center The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Myriam LabopinFaculté de Médicine Saint-Antoine and European Group of Blood and Bone Marrow Transplantation (EBMT) Data Office, Paris, France.
Shinichi KakoDivision of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
Karina Tozatto-MaioEurocord, Hospital Saint Louis, AP-HP, IUH University Paris VII, Paris, France.
Shingo YanoDivision of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Guillermo SanzHematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.ORCID http://orcid.org/0000-0002-2767-8191
Naoyuki UchidaDepartment of Hematology, Toranomon Hospital, Tokyo, Japan.
Maria Teresa Van LintOspedale San Martino Department of Haematology II, Genova, Italy.
Seiko KatoDepartment of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Mohamad MohtyDepartment of Pediatric Hematology and Oncology, IRCCS Bambino Gesù Children's Hospital, Roma, Italy.
Edouard ForcadeService d'hematologie et therapie cellulaire, CHU Bordeaux, 33000, Bordeaux, France.
Heiwa KanamoriDepartment of Hematology, Kanagawa Cancer Center, Yokohama, Japan.
Jorge SierraHospital Santa Creu i Sant Pau Hematology Department, Barcelona, Catalunya, Spain.
Yuju OhnoDepartment of Internal Medicine, Kitakyushu Municipal Medical Center, Kitakyushu, Japan.
Riccardo SaccardiAzienda Ospedaliera Universitaria Careggi Cell Therapy and Transfusion Medicine Unit, Firenze, Italy.
Takahiro FukudaHematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
Tatsuo IchinoheDepartment of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
Minoko TakanashiBlood Service Headquarters, Japanese Red Cross Society, Tokyo, Japan.
Vanderson RochaEurocord, Hospital Saint Louis, AP-HP, IUH University Paris VII, Paris, France.
Shinichiro OkamotoDivision of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
Arnon NaglerFaculté de Médicine Saint-Antoine and European Group of Blood and Bone Marrow Transplantation (EBMT) Data Office, Paris, France.
Yoshiko AtsutaJapanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.
Eliane GluckmanEurocord, Hospital Saint Louis, AP-HP, IUH University Paris VII, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Large differences in patient and transplant backgrounds make it difficult to identify consistent prognostic factors of unrelated cord blood transplantation (UCBT) among different populations. Thus, we performed a collaborative study between Eurocord/ALWP-EBMT and JSHCT/JDCHCT. Adults with acute leukaemia who underwent a single UCBT were eligible. In total, 3764 and 1027 patients of the JSHCT/JDCHCT and Eurocord/ALWP-EBMT registries, respectively, were included. The median ages of the Japanese and European cohorts were 51 and 38 years, respectively. Three or more HLA mismatches were more frequently observed in the Japanese cohort. The median total nucleated cell (TNC) counts were 2.58 and 3.51 × 10

Indexed as

AdultAgedCord Blood Stem Cell TransplantationDisease-Free SurvivalEuropeFemaleHumansJapanLeukemia, Myeloid, AcuteMaleMiddle AgedPrognosisTreatment Outcome

Identifiers

PMID31409921

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.